Class 4 drug alert – Caution in Use – Potassium chloride containing intravenous infusions

03 Jun 2019

A Class 4 drug alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for certain batches of potassium chloride containing intravenous infusions

Class 4 drug alert – Caution in Use

Ref: EL (19)A/13

Date 03 June 2019

Potassium chloride containing intravenous infusions

(Manufactured by Baxter Healthcare Ltd)

PL 00116/0336 (Potassium chloride 0.15% w/v and Sodium chloride 0.9% w/v solution for infusion- BP, 1000ml, Product code FKE1764)

PL 00116/0337 (Potassium chloride 0.3% w/v and sodium chloride 0.9% w/v solution for infusion, 1000ml, Product code FKE1984)

PL 00116/0656 (Potassium chloride 0.15% w/v and glucose 10% w/v solution for infusion, 500ml, Product code FE3737)

 

A Class 4 drug alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for certain batches of potassium chloride containing intravenous infusions.

Further information can be found on the MHRA section on the GOV.UK website.

Produced by the NPA Pharmacy Services team June 2019.